Literature DB >> 15855564

End-stage renal disease due to diabetes among southwestern American Indians, 1990-2001.

Nilka Ríos Burrows1, Andrew S Narva, Linda S Geiss, Michael M Engelgau, Kelly J Acton.   

Abstract

OBJECTIVE: This study assesses trends in the incidence of diabetes-related end-stage renal disease (ESRD) among southwestern American Indians (SWAIs). RESEARCH DESIGN AND METHODS: Using the U.S. Renal Data System, we obtained the total number of new cases of treated ESRD in which diabetes was the primary cause of renal failure in 1990 through 2001. The incidence of diabetes-related ESRD was calculated using census population figures and estimates of the SWAI population with diabetes, then age-adjusted to the 2000 U.S. population.
RESULTS: Between 1990 and 2001, the annual number of new patients starting treatment for diabetes-related ESRD in the SWAI total population increased from 154 to 320, and the age-adjusted diabetes-related ESRD incidence per 10,000 population increased 34% (6.2-8.3 per 10,000 people). However, after adjusting for the increasing number of people with diabetes in the SWAI population between 1993 and 2001, the age-adjusted incidence of diabetes-related ESRD among SWAIs with diabetes decreased 31%, from 80.4 to 55.8 per 10,000 people with diabetes. It decreased for both sexes and in all age-groups.
CONCLUSIONS: The increasing incidence of diabetes-related ESRD in the SWAI population parallels the growing prevalence of diabetes. However, since 1993 diabetes-related ESRD incidence decreased in the SWAI population with diabetes, consistent with national trends. This may reflect the reduction in risk factors and improvements in diabetes care practices in Indian communities.

Entities:  

Mesh:

Year:  2005        PMID: 15855564     DOI: 10.2337/diacare.28.5.1041

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

Review 1.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

2.  Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken.

Authors:  Michael Lynge Pedersen
Journal:  Int J Circumpolar Health       Date:  2019       Impact factor: 1.228

3.  Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.

Authors:  Ying Jiang; Nathaniel Osgood; Hyun-Ja Lim; Mary Rose Stang; Roland Dyck
Journal:  CMAJ       Date:  2013-12-02       Impact factor: 8.262

4.  Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program.

Authors:  Stacey E Jolly; Suying Li; Shu-Cheng Chen; Andrew S Narva; Claudine T Jurkovitz; Keith C Norris; Michael G Shlipak
Journal:  Am J Nephrol       Date:  2008-11-14       Impact factor: 3.754

5.  The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study.

Authors:  Mohamed G Atta; Kesha Baptiste-Roberts; Frederick L Brancati; Tiffany L Gary
Journal:  Am J Med       Date:  2009-01       Impact factor: 4.965

6.  Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study.

Authors:  Roland F Dyck; Mariam Naqshbandi Hayward; Stewart B Harris
Journal:  BMC Nephrol       Date:  2012-07-09       Impact factor: 2.388

7.  Preventing diabetes in American Indian communities.

Authors:  William C Knowler; Ronald T Ackermann
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

Review 8.  Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.

Authors:  Rachel Reilly; Katharine Evans; Judith Gomersall; Gillian Gorham; Micah D J Peters; Steven Warren; Rebekah O'Shea; Alan Cass; Alex Brown
Journal:  BMC Health Serv Res       Date:  2016-04-06       Impact factor: 2.655

Review 9.  The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Authors:  Maria Narres; Heiner Claessen; Sigrid Droste; Tatjana Kvitkina; Michael Koch; Oliver Kuss; Andrea Icks
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

10.  Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.

Authors:  Aowen Zhuang; Felicia Y T Yap; Domenica McCarthy; Chris Leung; Karly C Sourris; Sally A Penfold; Vicki Thallas-Bonke; Melinda T Coughlan; Benjamin L Schulz; Josephine M Forbes
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.